Individualizing radiotherapy according to levels of a patient-specific biomarker of liver function safely achieves local control in cancer patients at high risk for liver damage. READ MORE

News

Individualizing radiotherapy according to levels of a patient-specific biomarker of liver function safely achieves local control in cancer patients at high risk for liver damage.

READ MORE

Death rates from liver cancer in the US have doubled since the 1980s and continue to rise, largely due to risk factors like hepatitis that should be the focus of better treatment and prevention efforts.

READ MORE

Curative therapies are more likely to be prescribed when liver cancer patients are evaluated by a multidisciplinary team of specialists.

READ MORE

A simplified prognostic score may increase the accuracy of survival prediction after hepatectomy for intrahepatic cholangiocarcinoma.

READ MORE

Research in Review

A conventional second-line treatment for hepatocellular carcinoma offers only a marginal increase in quality-adjusted life-years at a significantly high cost.

READ MORE

Researchers aimed to evaluate the safety, utilization, and cost of percutaneous liver biopsy over the last 10 years in a study published in Cancer Investigation. 

READ MORE